Pain and analgesia Flashcards

1
Q

what is the World Health Organisations definition of pain?

A

1) an unpleasant sensory or emotional experience associated with actual or potential tissue damage, or described in terms of such damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how are patients asked to indicate the degree of pain they are experiencing?

A

1) Pain scales where patient is asked to indicate degree of pain in relation to extremes
- can be a numerical scale 0 (no pain) to 10 (worse pain)
- Visual Analogue Scale ( mark along the scale)
2) Rating scales: patient asked to indicate degree of pain:
- word descriptor scales ( e.g. 0= no pain, 2 = distressing pain, 5 = excruciating pain…)
- verbal scale (On a scale of 0 to 10…)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

other scales used to indicate pain are functional and categorical scales. describe these scales

A

1) functional scales:e.g. 0= no pain, 1 = tolerable and pain does not prevent any activities, 5 = intolerable and pain prevents verbal communication
2) Categorical scale: Mild (1-3) , Moderate (4-6), Severe (7-10)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Graphic scales can also be used to rate pain. what are graphic scales and when would they be used?

A

1) uses smiley faces: 0 = Very happy, no hurt :), 10= Hurts as much as you can imagine :(.
2) used for young/disabled patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

list five scales used to indicate pain

A

1) word descriptor scale
2) verbal scale
3) functional scale
4) Categorical scale
5) graphic scale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pain is multifactorial, but can be divided into 2 broad sub-classes. name the two sub-classes

A

1) Nociceptive pain

2) Neuropathic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

1) what is Nociceptive pain ?

2) give examples of Nociceptive pain

A

1) Peripheral visceral or somatic pain due to direct activation of pain-sensing receptors (nociceptors) in response to a noxious stimulus that alerts the organism of impending tissue damage
2) Examples: inflammation, fractures, burns, bumps & bruises

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the two types of Nociceptive pain?

A

1) acute : lasting < 3-6 months, desirable defence mechanism

2) chronic : lasting >6 months, undesirable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

1) what is Neuropathic pain ?

2) give examples of Neuropathic pain

A

1) Pain produced by damage to, or dysfunction of, nerves in the peripheral or central nervous system
2) Examples: trigeminal neuralgia, nerve trauma, peripheral neuropathy, phantom limb pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Is Neuropathic pain chronic or acute?

A

1) Neuropathic pain tends to be chronic, but can also be acute
(e. g. following surgery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nociceptive pain perception may be viewed as a three-stage process. outline these 3 stages

A

1) Detection of pain in the periphery. Noxious stimuli (to skin or subcutaneous tissue) activates sensory nociceptors
2) Transmission of pain signals from the periphery to spinal cord, predominantly by C-fibres and Aδ -fibres. Signals are amplified or inhibited by local neuronal circuits and descending inhibitory pathways from higher brain centers
3) Reception of signal by higher central brain centers, afferent activity generates a pain sensation and initiates an appropriate response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name the three mine types of fibres involved in sensory transduction and state their function.

A

1) Aβ: touch/pressure (mechanoreception). Likely target of TENS and acupuncture
2) Aδ: signal sharp pain (nociceptors)
3) C: Dull, burning pain (nociceptors)
- Temperature (thermoceptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

state the diameter, conduction velocity and myelination for the following fibres.

1) Aβ
2) Aδ
3) C

A

1) Aβ: diameter= 5-10ɥm
- conduction velocity (m/s)= 30-70
- myelination: thick
2) Aδ: diameter= 2-5ɥm
- conduction velocity (m/s)= 5-30
- myelination: thin
3) C: diameter= ~1ɥm
- conduction velocity (m/s)= < 1
- myelination: none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

outline the gate control theory proposed by Melzack and Wall

A

1) perception of pain may be controlled by a ‘gate
2) The gate is formed by transmission neurones which supply the thalamus and are affected by small inhibitory neurones (substantia gelatinosa SG interneurones) and by nociceptive (C and Aδ fibres) and mechanoreceptor (Aβ) fibre input.

( The smaller, unmyelenated A (delta) and C nerve fibers sense pain such as sharp burning and aching feelings. Larger, myelenated A (beta) skin nerves which carry senses of touch, heat, cold and pressure. the A (beta) nerves are faster, and also have priority which effectively blocks out the pain messages to the brain and closes the gate.) -> google

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

summarise the role of the following in the gate control theory:

1) SG (substantia gelatinosa)
2) C/Aδ fibres
3) Aβ
4) Descending inhibitory pathways from the CNS

A

1) SG interneurones inhibit (close) the gate: reduce pain
2) Activation of C/Aδ fibres open the gate (increase pain) by: direct excitation of the gate, inhibition of SG interneurones
3) Activation of Aβ fibres close the gate by: excitation of SG interneurones
4) Descending inhibitory pathways from the CNS close the gate by: inhibition of the gate, direct activation of SG interneurones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

targeting inflationary mediators is the basis for designing analgesic drugs. list the Inflammatory mediators of peripheral pain and state their function.

A

1) Bradykinin activates :
- B₂ receptors in nociceptive neurones
- B₁ receptors: via the metabolite des-Arg⁹BK; ‘upregulated’ by inflammation
2) Substance P: activate NKA (neurokinin) receptors in nociceptive neurones
3) Adenosine triphosphate (ATP): activate P₂X₃ receptors
4) Protons (H+): activate Acid-Sensing Ion Channels (ASICs)
5) Endogenous activators of TRPV1 vanilloid receptors also heat, target of capsaicin . TRPV1 upregulated by BK and Nerve Growth Factor (NGF)
6) Prostanoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

1) what are Prostanoids and when are they released?
2) what do Prostanoids cause?
3) how can the release of these mediators be blocked?

A

1) Prostanoids are released in inflammation (prostaglandins and thromboxane) produced from precursors in cell membrane
2) cause release of two mediators, PGE2 and PGF2 released in inflammation, greatly increase responses to bradykinin and 5-HT = sensitization (more painful)
3) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as aspirin block the cyclooxygenase enzyme which breaks down arachidonic acid into all of the above mediators.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

outline the Important neurotransmitters involved in transmitting Nociceptive pain impulses to higher brain centres.

A

1) Glutamate (excitatory amino acid) acts at:
- AMPA receptors mediate acute pain (fast response, sets baseline)
- NMDA receptors (delayed response)
2) Substance P (often co-released with glutamate) acts at NK1 (NKA) receptors to enhance NMDA action (hypersensitivity). Often CGRP (peptide) is co-released
3) this leads to Nitric oxide (NO) release which enhances further transmission of pain signal (hyperalgesia)
- positive feedback as NO causes more and more Glutamate to be released

19
Q

1) outline the causes of Neuropathic pain.

2) what does neuropathic pain feel like?

A

1) Damage to peripheral (neuralgia, neuropathy due to injury or infection eg. shingles) or central (trauma, stroke, MS) nerves.
2) Neuropathic pain may be described as:
severe, sharp, burning, cold, producing numbness, tingling or weakness.
- May be felt traveling along the nerve path from the spine to the periphery.

20
Q

physiologically we dont really know what causes neurophatic pain which is why there is no really good first line therapeutics. discuss some of the ideas behind what causes neuropathic pain

A

1) Sodium channel clustering: Redistribution of sodium channels to areas of nerve damage can set up ectopic (out of place) firing
2) Sympathetic NS-mediated pain: Upregulation of α-adrenoceptors means that NA release causes pain

21
Q

what is the therapy for Nociceptive pain?

A

non-opioid (paracetamol, aspirin and other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)) and opioid analgesics are the main drugs used to treat pain
- Non-opioids are limited by ceiling effect (dose above which there is no further pharmacological action)

22
Q

what is the therapy for Neuropathic pain?

A

Neuropathic pain (and chronic pain): antidepressants, anticonvulsants, and other CNS-active drugs may also be used and are first-line therapy for some conditions

23
Q

Non-Opioid Drugs such as aspirin and paracetamol can be used together for mild to moderate pain. outline the MOA of aspirin

A

1) Blocks cyclooxygenase (COX) enzymes: COX-1 and COX-2 (induced at the site of damage) isoforms
2) COX-1 associated with gastroprotection, therefore COX-2-selective drugs (‘coxibs’) sought

24
Q

1) what are NSAIDs used for?

A

1) acute mild to moderate pain or chronic disease accompanied by pain and inflammation
2) NSAIDs also widely used to prevent blood clots and as anti-pyretic (reduce fever) and anti-inflammatory agents
3) Dose used to treat inflammation is typically higher and time-course is longer (up to 3 weeks) compared to analgesia (~ 1 week)

25
Q

1) what is aspirin indicated for?

2) what are the disadvantages of using aspirin?

A

1) Used in headache, transient musculoskeletal pain, dysmenorrhoea (period pain) etc.
2) Due to gastric irritant effects (via COX-1 block) and anti-platelet effects (via TXA2 effect), other NSAIDs typically recommended for analgesia

26
Q

1) what are Non-selective NSAIDs?

2) give examples of Non-selective NSAIDs

A

1) inhibit both types of the COX enzyme and thus are associated with an increased risk of gastric ulceration, through reduction in gastric protection and irritation of the gastric lining
2) Indoles: diclofenac or indomethacin
- Propionic acid derivatives: ibuprofen, naproxen and ketoprofen

27
Q

1) what are the benefits of COX-2 selective NSAIDs ‘coxibs’?
2) give examples of COX-2 selective drugs and their indication
3) what are the disadvantages of these drugs?

A

1) Selective COX-2 inhibitors directly targets COX-2. Targeting selectivity for COX-2 reduces the risk of peptic ulceration, and is the main feature of celecoxib, rofecoxib and other members of this drug class.
2) Celecoxib and etoricoxib are licenced in the UK to treat pain in osteoarthritis and rheumatoid arthritis and ankylosing spondylitis; etoricoxib is also licensed for the relief of pain from acute gout.
3) All carry a warning for cardiovascular risk.

28
Q

what is Nefopam?

A

Nefopam is a non-opioid analgesic which can be used for persistent pain if NSAIDs are not effective. Causes little or no respiratory depression (associated with opioids), but can have sympathomimetic and antimuscarinic side-effects.

29
Q

Paracetamol is a non-opioid drug, lacks anti-inflammatory effects and so is not an NSAID. outline the MOA of paracetamol

A

1) Paracetamol is an effective analgesic believed to work by reducing the production of prostaglandins in the brain and spinal cord
2) Mechanism of action: TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol.

30
Q

1) what are compound analgesics?

2) list some compound analgesic preparations

A

1) Combination of a non-opioid (such as aspirin or paracetamol) with an opioid to manage of pain of varying intensity.
2) - Co-codamol 8/500 (8 mg codeine phosphate:500 mg paracetamol) [p]
- Co-codamol 30/500 [POM]: effective in more severe pain, but accompanied with opioid side effects
- co-dyramol: paracetamol with dihydrocodeine tartrate)

31
Q

1) What are opioids?

2) give examples of opioid receptor agonists

A

1) Opioids are morphine-like drugs whose effects are blocked by naloxone, act spinally and supra-spinally to produce analgesia in moderate to severe pain (post-operative, cancer pain)
2) agonists : Morphine, Pethidine, Methadone
- Naloxone (antagonist)
- Opioids are agonists which inhibit presynaptic receptors = block pain signals

32
Q

name the 4 opioid receptor subtypes and state their endogenous agonists.

A

1) delta (δ): β-endorphin enkephalins
2) kappa (k): β-endorphin dynorphins
3) mu (μ): β-endorphin, endomorphins
4) N/OFQ Nociceptin / orphanin FQ: nociceptin

33
Q

state the therapeutic agonists for each of the following receptors:

1) kappa (k)
2) mu (μ)

A

1) kappa (k):pentazocine

2) mu (μ): morphine, codeine, fentanyl, pethidine etc

34
Q

what is the MOA of opioids?

A

1) Spinal action:Activate pre-synaptic μ > δ receptors to reduce transmitter release
2) Supra-spinal action: Opioid action at μ (δ and k) receptors enhance descending inhibitory pathway in brain stem/midbrain involving NA and 5-HT release (by blocking GABA inhibition)

35
Q

discuss the clinical uses of opioid agonists

A

All act at δ receptors (except pentazocine, k agonist) used to treat all forms of severe nociceptive pain eg. accidents, pre-, post-operative pain, cancer pain; reportedly less useful in neuropathic pain

36
Q

discuss the use of morphine therapeutically

A

1) Morphine: ‘gold standard’ to which all opioids are compared.
2) reduces the affective component of pain
3) metabolised to potent analgesic morphine-6-glucuronide
4) dose typically titrated against amount of pain relief
commonly given IV or orally as morphine sulphate tablets (MST)

37
Q

opioid drugs Differ only in potency and pharmacokinetics. state the indication of the following opioids:

1) Fentanyl
2) Pethidine
3) Oxycodone
4) Dihydrocodeine
5) Tramadol

A

1) Fentanyl: very potent, short-duration, often used as a transdermal patch
2) Pethidine: used during labour (due to lack of effect on uterine contraction)
3) Oxycodone: used primarily for control of pain in palliative care.
4) Dihydrocodeine: similar efficacy to codeine
- can cause more nausea and vomiting
5) Tramadol: weak opioid and an inhibitor of the noradrenaline uptake/transport system

38
Q

name an opioid drug which is a partial agonist

A

Buprenorphine: long duration, can be given sublingually

39
Q

what are the benefits of using low dose codeine and what are the disadvantages?

A

1) Codeine: low efficacy, orally effective drug. Not addictive, so widely used for mild pain such as back-, head- and toothache
2) causes constipation with long-term use

40
Q

discuss the Side-effects of opioid agonists

A

1) Respiratory depression: reduces sensitivity of respiratory centre; most common cause of death from overdose with street use of opioids; treated with naloxone.
2) Euphoria: action on reward pathway in the brain to increase dopamine release
3) Cough suppression (anti-tussive): can be therapeutically useful
4) Nausea: activate the chemoreceptor trigger zone (which in turn activates the vomiting centre) - anti-emetics typically co-prescribed
5) Constipation: due to maintained contraction of smooth muscle (Kaolin & Morphine used as an anti-diarrheal agent)

41
Q

Opioids and NSAID’s are usually not that effective for Neuropathic pain. Treatments for neuropathic pain include a variety of drugs generally used for chronic pain. list some of these drugs

A

1) Antiepileptic drugs: Carbamazepine, phenytoin (sodium channel blockers) and gabapentin, pregabalin (via effects on calcium channels)
2) Tricyclic antidepressants: Duloxetine and imipramine/amitriptyline effective in conditions such as in diabetic neuropathy
3) Ketamine: due to block of NMDA receptors
4) Lidocaine or bupivacaine: Local anaesthetics which block sodium channels when injected close to a sensory nerve
5) Ziconotide: administered intrathecal infusion to treat neuropathic pain
6) Cannabinoid agonists: Sativex- licenced in UK to treat pain in multiple sclerosis patients.

42
Q

describe the WHO pain ladder

A

If pain occurs, there should be prompt oral administration of drugs in the following order:

1) non- opioids (aspirin and paracetamol); then, as necessary,
2) mild opioids (compound analgesic or weak opioid)
3) then strong opioids such as morphine, until the patient is free of pain.

43
Q

what are the treatment options for the following:

1) Musculoskeletal and dental pain, period pain
2) Mild, inflammatory pain (sprains)
3) Severe, acute pain
4) Severe, chronic pain
5) Neuropathic pain generally unresponsive to opioids

A

1) paracetamol or NSAIDs
2) co-codamol, codeine, dihydrocodeine
3) strong opioid IV- morphine, fentanyl
4) treated by oral, intrathecal or subcutaneous strong opioid-morphine, fentanyl
5) amitripyline, pregabalin